this research has put forth that the Latin America sleep apnea therapeutics and diagnostics market is likely to progress with a CAGR of 6.50% in the forecasting years 2021-2028. Brazil, Mexico, and Rest of Latin America together make the market in this region.
Sleep apnea is highly prevalent in Brazilians. Lancet’s study on obstructive sleep apnea, in July 2019, estimated that a staggering 26% of people in the country, aged 30 to 69 years, were found to be suffering from moderate to severe sleep apnea. And the severity of this condition is anticipated to rise owing to the limited treatment options available and the unfavorable reimbursement policies for the same.
For treatment, patients here prefer PAP therapy. Also, oral appliances for sleep apnea are also highly used by them. According to a study by the National Center for Biotechnology Information (NCBI), the usage of oral appliances has reduced breathing disorders, snoring incidences, sleep-wake transition disorders, nightmares, etc. It has also increased the blood oxygen levels in pediatric sleep apnea patients. In the wake of the ongoing pandemic, the local startups in Brazil are coming up with novel solutions for sleep monitoring. For example, Biologix, has developed a new sleep screening and monitoring device. The growing adoption of such devices is expected to propel the market growth in Brazil in the coming years.
Sleep apnea is highly prevalent in Brazilians. Lancet’s study on obstructive sleep apnea, in July 2019, estimated that a staggering 26% of people in the country, aged 30 to 69 years, were found to be suffering from moderate to severe sleep apnea. And the severity of this condition is anticipated to rise owing to the limited treatment options available and the unfavorable reimbursement policies for the same.
For treatment, patients here prefer PAP therapy. Also, oral appliances for sleep apnea are also highly used by them. According to a study by the National Center for Biotechnology Information (NCBI), the usage of oral appliances has reduced breathing disorders, snoring incidences, sleep-wake transition disorders, nightmares, etc. It has also increased the blood oxygen levels in pediatric sleep apnea patients. In the wake of the ongoing pandemic, the local startups in Brazil are coming up with novel solutions for sleep monitoring. For example, Biologix, has developed a new sleep screening and monitoring device. The growing adoption of such devices is expected to propel the market growth in Brazil in the coming years.
COMPETITIVE OUTLOOK
The eminent names in the sleep apnea therapeutics and diagnostics market are Invacare Corporation, Nihon Kohden Corporation, Teleflex Incorporated, Koninklijke Philips NV, Fisher & Paykel Healthcare Corporation Limited, Devilbiss Healthcare LLC, Signifier Medical Technologies Limited, and Cadwell Industries Inc.Table of Contents
1. Latin America Sleep Apnea Therapeutics and Diagnostics Market - Summary
2. Industry Outlook
3. Latin America Sleep Apnea Therapeutics and Diagnostics Market - by Product Type
4. Latin America Sleep Apnea Therapeutics and Diagnostics Market - by Industry Verticals
5. Geographical Analysis - Latin America
6. Competitive Landscape
7. Research Methodology & Scope
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- BMC Medical Co Ltd
- Braebon Medical Corporation
- Cadwell Industries Inc
- Devilbiss Healthcare LLC
- Fisher & Paykel Healthcare Corporation Limited
- GE Healthcare (General Electric Company)
- Invacare Corporation
- Itamar Medical Ltd
- Koninklijke Philips Nv
- Medtronic plc
- Nihon Kohden Corporation
- Signifier Medical Technologies Limited
- Resmed Inc
- Smiths Medical Inc
- Somnomedics GmbH
- Teleflex Incorporated
- Vyaire Medical Inc
Methodology
LOADING...